Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelet lysate is an acellular, protein-rich biologic derived from the lysis of human platelets. It contains a concentrated mix of growth factors, cytokines, chemokines, and proteins that play key roles in tissue repair and regeneration. Platelet lysate is produced by breaking open platelets (typically via freeze-thaw cycles), which releases their contents while removing cellular debris and surface antigens to minimize immunogenicity[2][6]. The resulting solution is rich in growth factors such as platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), fibroblast growth factor (FGF), and others[5][6]. These components stimulate cell proliferation, angiogenesis, collagen synthesis, differentiation of stem cells into target tissues like bone or cartilage, and reduce inflammation[1][4][5]. Platelet lysate has been investigated for use in regenerative medicine for conditions including musculoskeletal injuries, osteoarthritis, oral mucositis, radicular pain syndromes, alopecia, acute lung injury/ARDS/COVID-19-related respiratory distress syndrome[1][2], as well as for enhancing stem cell culture expansion ex vivo[3]. Its mechanism centers on providing a high local concentration of bioactive molecules that promote healing without the pro-inflammatory effects sometimes seen with other blood-derived products like PRP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet lysate.